home / stock / cccc / cccc articles

CCCC Articles, C4 Therapeutics Inc. - From 12/13/23

Stock Information
Company Name: C4 Therapeutics Inc.
Stock Symbol: CCCC
Market: NASDAQ
Menu
CCCC CCCC Quote CCCC Short CCCC News CCCC Articles CCCC Message Board
Get CCCC Alerts

News, Short Squeeze, Breakout and More Instantly...
D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Crude Oil Down 4%; Aditxt Shares Spike Higher | Benzinga

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Tuesday. The Dow traded up 0.32% to 36,520...

Why Johnson Controls International Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session | Benzinga

Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results. Johnson Contr...

Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results | Benzinga

U.S. stocks turned higher midway through trading, with the Dow Jones index gaining more than 100 points on Tuesday. The Dow traded up 0.35% to 36,5...
US Stocks Edge Lower; Inflation Rate Slows to 3.1% In November | Benzinga

U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday. Following the market opening Tuesday, the Dow t...

Why Is Cancer-Focused C4 Therapeutics Stock Soaring Today? | Benzinga

C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: ...

C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment | Benzinga

WATERTOWN, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedica...
Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Gainers INVO Bioscience, Inc. (NASDAQ: INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction. L...

C4 Therapeutics Announces Upcoming Data Presentations for CFT8634, an Orally Bioavailable BiDAC™ Degrader in Development for Synovial Sarcoma and SMARCB1-Null Tumors, and CFT7455, an Orally Bioavailable MonoDAC™ Degrader in Development for Multiple Myelom

CFT8634 Phase 1 Dose Escalation Data to be Presented at the Connective Tissue Oncology Society Annual Meeting on November 2, 2023 CFT7455 Monother...

C4 Therapeutics Chief People Officer Awarded $267K Worth of Stock Options | Benzinga

Kelly Schick, Chief People Officer at C4 Therapeutics (NASDAQ:CCCC), reported a large acquisition of company stock options on September 19, accordi...
Previous 10 Next 10